Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Transgene Capital/Financing Update 2017

Jan 5, 2017

1715_rns_2017-01-05_f71c707a-680c-433b-8180-b3edf53e1c11.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

Strasbourg, January 5, 2017 – 06:00pm CET

Half-Year Report on the Transgene Liquidity Contract with Kepler Cheuvreux

Under the liquidity contract between Transgene and Kepler Cheuvreux, on December 30, 2016, the resources provided for market making activities consisted of:

  • 49,348 Transgene Shares
  • € 389,427.04

For information, as of June 30, 2016, the resources provided for market making activities consisted of :

  • 2 000 Transgene Shares
  • € 495,000

Contacts

.

Transgene

Lucie Larguier Director Corporate Communications & IR +33 (0)3 88 27 91 04

[email protected]